Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-11 Sale | 2024-03-12 8:07 pm | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 13,201 | $3.4064 | $44,968 | 372,979 (Direct) | View |
2024-03-11 Sale | 2024-03-12 8:04 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 29,768 | $3.3125 | $98,605 | 649,156 (Indirect Direct) | View |
2024-03-11 Sale | 2024-03-12 8:01 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 183,238 | $3.1694 | $580,760 | 2,552,499 (Direct) | View |
2023-10-16 Sale | 2023-10-18 5:15 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2,756,499 | $1.6156 | $4,453,308 | 8,593,586 (Indirect) | View |
2022-08-09 Purchase | 2022-08-11 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 115,000 | $7.5457 | $867,750 | 11,350,085 (Indirect) | View |
2022-08-08 Purchase | 2022-08-10 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 97,000 | $7.24 | $702,280 | 11,235,085 (Indirect) | View |
2022-08-05 Purchase | 2022-08-09 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 141,000 | $6.95 | $979,950 | 11,138,085 (Indirect) | View |
2022-08-04 Purchase | 2022-08-08 4:09 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 95,100 | $6.17 | $586,767 | 10,997,085 (Indirect) | View |
2022-08-03 Purchase | 2022-08-05 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 100,000 | $5.84 | $584,000 | 10,901,985 (Indirect) | View |
2022-08-02 Purchase | 2022-08-04 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 412,406 | $5.59 | $2,305,350 | 10,801,985 (Indirect) | View |
2022-08-01 Purchase | 2022-08-03 5:16 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 144,185 | $5.05 | $728,134 | 10,389,579 (Indirect) | View |
2022-07-29 Purchase | 2022-08-02 4:27 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 222,123 | $5.03 | $1,117,279 | 10,245,394 (Indirect) | View |
2022-07-28 Purchase | 2022-08-01 5:37 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 119,392 | $5 | $596,960 | 10,023,271 (Indirect) | View |
2022-06-23 Purchase | 2022-06-27 06:42 am | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 4,323 | $3.4755 | $15,025 | 23,967 (Direct) | View |
2022-06-23 Purchase | 2022-06-27 06:41 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-09 Option Award | 2024-03-12 8:07 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 252,280 | $0 | 372,979 (Direct) | View |
2024-03-09 Option Award | 2024-03-12 8:04 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 405,450 | $0 | 649,156 (Direct) | View |
2024-03-09 Option Award | 2024-03-12 8:01 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 1,081,201 | $0 | 2,552,499 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0.552 | 1,654,536 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0 | 1,654,536 (Direct) | View |
2023-09-07 Tax Withholding | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 73,807 | $7.22 | 1,654,536 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 4:31 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 5,437 | $0.552 | 14,812 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 4:31 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 5,437 | $0 | 14,812 (Direct) | View |
2023-08-22 Exercise | 2023-08-24 4:13 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 9,604 | $0.552 | 15,854 (Direct) | View |
2023-08-22 Exercise | 2023-08-24 4:13 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 9,604 | $0 | 15,854 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:46 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 24,606 | $0 | 24,606 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:43 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 24,423 | $0 | 24,423 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:42 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 22,137 | $0 | 22,137 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:34 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 24,058 | $0 | 24,058 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:32 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 27,350 | $0 | 27,350 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 5:30 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 22,137 | $0 | 22,137 (Direct) | View |
2023-06-27 Exercise | 2023-06-29 4:23 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 9,604 | $0.552 | 28,248 (Direct) | View |
2023-06-27 Exercise | 2023-06-29 4:23 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 9,604 | $0 | 28,248 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:27 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 220,258 | $0 | 220,258 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:25 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 110,028 | $0 | 110,028 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:22 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 488,750 | $0 | 1,705,285 (Direct) | View |
2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 604,308 | $0 | 604,308 (Direct) | View |
2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 126,087 | $0 | 133,900 (Direct) | View |
2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 255,078 | $0 | 342,947 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:07 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 62,394 | $0 | 62,394 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:07 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 56,131 | $0 | 56,131 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 61,930 | $0 | 61,930 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 61,002 | $0 | 61,002 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 69,353 | $0 | 69,353 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 5:04 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 56,131 | $0 | 56,131 (Direct) | View |
Ownership | 2022-05-13 4:28 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 0 | $0 | 333,685 (Direct) | View |
2022-03-30 Option Award | 2022-04-01 7:44 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 457,758 | $0 | 1,656,593 (Direct) | View |
2022-03-30 Option Award | 2022-04-01 7:37 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua Chief Financial Officer | 343,322 | $0 | 524,825 (Direct) | View |